- Home
- UNCY vs BSET Comparison
UNCY vs BSET Comparison
Compare UNCY & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNCY | BSET |
|---|---|---|
| Founded | 2016 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.8M | 153.2M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | UNCY | BSET |
|---|---|---|
| Price | $7.07 | $14.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $44.50 | N/A |
| AVG Volume (30 Days) | ★ 473.7K | 20.1K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | ★ 5.38% |
| EPS Growth | 56.25 | ★ 163.06 |
| EPS | N/A | ★ 0.70 |
| Revenue | $675,000.00 | ★ $456,855,000.00 |
| Revenue This Year | N/A | $4.63 |
| Revenue Next Year | N/A | $4.34 |
| P/E Ratio | ★ N/A | $21.33 |
| Revenue Growth | N/A | ★ 0.96 |
| 52 Week Low | $0.45 | $13.96 |
| 52 Week High | $7.57 | $19.75 |
Technical Indicators
Market Signals| Indicator | UNCY | BSET |
|---|---|---|
| Relative Strength Index (RSI) | 58.77 | 45.24 |
| Support Level | $5.90 | $14.55 |
| Resistance Level | $7.43 | $17.29 |
| Average True Range (ATR) | 0.34 | 0.55 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 88.71 | 34.13 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.